About RECOTHROM:
RECOTHROM Thrombin, topical (Recombinant) is the first human thrombin approved by the US Food and Drug Administration that is produced via recombinant DNA technology. Recombinant proteins have opened up a new era of therapeutic care for a number of health conditions. Numerous recombinant proteins have been brought to market as alternatives to proteins derived from human and animal plasma: examples include human insulin and several human blood coagulation factors, among others. These proteins have been used safely and effectively for many different therapeutic indications. The availability of RECOTHROM offers a thrombin alternative that is not derived from human or animal plasma.
Share in the benefits of recombinant technology
- 100% free of human or animal plasma
- Minimizes the risk of transmitting blood-borne pathogens
- No Black Box warning required, based on available safety and immunogenicity data
- Limited data are available on repeat exposure to RECOTHROM
- State-of-the-art recombinant manufacturing processes provide consistent quality and product availability
RECOTHROM is a registered trademark of ZymoGenetics, Inc.
©2010 by ZymoGenetics, Inc. All rights reserved.
